Annual Operating Profit
-$28.49 M
+$6.75 M+19.14%
31 December 2023
Summary:
Alaunos Therapeutics annual operaing income is currently -$28.49 million, with the most recent change of +$6.75 million (+19.14%) on 31 December 2023. During the last 3 years, it has risen by +$51.87 million (+64.54%). TCRT annual operating profit is now -71311.03% below its all-time high of -$39.90 thousand, reached on 31 December 2002.TCRT Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$1.15 M
+$16.00 K+1.37%
30 September 2024
Summary:
Alaunos Therapeutics quarterly operating income is currently -$1.15 million, with the most recent change of +$16.00 thousand (+1.37%) on 30 September 2024. Over the past year, it has increased by +$6.08 million (+84.10%). TCRT quarterly operating profit is now -25455.56% below its all-time high of -$4500.00, reached on 30 September 2000.TCRT Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$7.42 M
+$6.08 M+45.06%
30 September 2024
Summary:
Alaunos Therapeutics TTM operating income is currently -$7.42 million, with the most recent change of +$6.08 million (+45.06%) on 30 September 2024. Over the past year, it has increased by +$26.24 million (+77.96%). TCRT TTM operating profit is now -25391.41% below its all-time high of -$29.10 thousand, reached on 30 June 2000.TCRT TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TCRT Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +19.1% | +84.1% | +78.0% |
| 3 y3 years | +64.5% | +94.8% | +91.7% |
| 5 y5 years | +47.1% | +91.5% | +86.4% |
TCRT Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +64.5% | at high | +94.8% | at high | +91.7% |
| 5 y | 5 years | at high | +64.5% | at high | +95.0% | at high | +91.7% |
| alltime | all time | <-9999.0% | +82.8% | <-9999.0% | +99.1% | <-9999.0% | +95.7% |
Alaunos Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.15 M(-1.4%) | -$7.42 M(-45.1%) |
| June 2024 | - | -$1.17 M(-33.1%) | -$13.50 M(-34.3%) |
| Mar 2024 | - | -$1.74 M(-48.2%) | -$20.56 M(-27.8%) |
| Dec 2023 | -$28.49 M(-19.1%) | -$3.36 M(-53.6%) | -$28.49 M(-15.3%) |
| Sept 2023 | - | -$7.23 M(-12.1%) | -$33.65 M(-3.0%) |
| June 2023 | - | -$8.23 M(-14.9%) | -$34.68 M(-3.2%) |
| Mar 2023 | - | -$9.67 M(+13.5%) | -$35.82 M(+1.7%) |
| Dec 2022 | -$35.24 M(-54.1%) | -$8.52 M(+3.1%) | -$35.24 M(-4.8%) |
| Sept 2022 | - | -$8.26 M(-11.8%) | -$37.03 M(-27.5%) |
| June 2022 | - | -$9.37 M(+3.1%) | -$51.06 M(-20.6%) |
| Mar 2022 | - | -$9.09 M(-11.9%) | -$64.33 M(-16.2%) |
| Dec 2021 | -$76.81 M(-4.4%) | -$10.31 M(-53.8%) | -$76.81 M(-14.0%) |
| Sept 2021 | - | -$22.30 M(-1.5%) | -$89.27 M(+2.3%) |
| June 2021 | - | -$22.64 M(+5.0%) | -$87.30 M(+4.8%) |
| Mar 2021 | - | -$21.56 M(-5.3%) | -$83.26 M(+3.6%) |
| Dec 2020 | -$80.36 M(+38.9%) | -$22.77 M(+12.1%) | -$80.36 M(+9.2%) |
| Sept 2020 | - | -$20.32 M(+9.2%) | -$73.62 M(+10.3%) |
| June 2020 | - | -$18.61 M(-0.3%) | -$66.75 M(+6.1%) |
| Mar 2020 | - | -$18.66 M(+16.4%) | -$62.90 M(+8.7%) |
| Dec 2019 | -$57.86 M(+7.3%) | -$16.04 M(+19.2%) | -$57.86 M(+6.0%) |
| Sept 2019 | - | -$13.45 M(-8.8%) | -$54.58 M(+1.6%) |
| June 2019 | - | -$14.75 M(+8.3%) | -$53.71 M(+4.6%) |
| Mar 2019 | - | -$13.62 M(+6.7%) | -$51.33 M(-4.8%) |
| Dec 2018 | -$53.91 M(+0.8%) | -$12.76 M(+1.5%) | -$53.91 M(-1.2%) |
| Sept 2018 | - | -$12.57 M(+1.6%) | -$54.58 M(-0.9%) |
| June 2018 | - | -$12.38 M(-23.6%) | -$55.09 M(-1.1%) |
| Mar 2018 | - | -$16.20 M(+20.5%) | -$55.72 M(+4.2%) |
| Dec 2017 | -$53.49 M(-67.6%) | -$13.44 M(+2.7%) | -$53.49 M(+4.5%) |
| Sept 2017 | - | -$13.08 M(+0.5%) | -$51.17 M(+4.4%) |
| June 2017 | - | -$13.01 M(-6.8%) | -$49.00 M(-70.7%) |
| Mar 2017 | - | -$13.96 M(+25.7%) | -$167.23 M(+1.2%) |
| Dec 2016 | -$165.31 M(+37.6%) | -$11.11 M(+1.8%) | -$165.31 M(+1.0%) |
| Sept 2016 | - | -$10.91 M(-91.7%) | -$163.68 M(-4.2%) |
| June 2016 | - | -$131.24 M(+990.0%) | -$170.93 M(+217.0%) |
| Mar 2016 | - | -$12.04 M(+27.0%) | -$53.91 M(-55.1%) |
| Dec 2015 | -$120.10 M(+176.1%) | -$9.48 M(-47.8%) | -$120.10 M(-0.9%) |
| Sept 2015 | - | -$18.17 M(+27.7%) | -$121.21 M(+5.4%) |
| June 2015 | - | -$14.22 M(-81.8%) | -$114.99 M(+2.7%) |
| Mar 2015 | - | -$78.23 M(+638.3%) | -$111.94 M(+157.3%) |
| Dec 2014 | -$43.50 M(-24.6%) | -$10.60 M(-11.3%) | -$43.50 M(+9.8%) |
| Sept 2014 | - | -$11.94 M(+6.8%) | -$39.62 M(+7.7%) |
| June 2014 | - | -$11.18 M(+14.2%) | -$36.80 M(-16.2%) |
| Mar 2014 | - | -$9.78 M(+45.6%) | -$43.92 M(-23.9%) |
| Dec 2013 | -$57.71 M(-43.5%) | -$6.72 M(-26.3%) | -$57.72 M(-35.8%) |
| Sept 2013 | - | -$9.12 M(-50.2%) | -$89.84 M(-12.3%) |
| June 2013 | - | -$18.30 M(-22.4%) | -$102.45 M(-4.4%) |
| Mar 2013 | - | -$23.58 M(-39.3%) | -$107.12 M(+4.8%) |
| Dec 2012 | -$102.17 M | -$38.84 M(+78.8%) | -$102.17 M(+28.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2012 | - | -$21.73 M(-5.4%) | -$79.74 M(+10.4%) |
| June 2012 | - | -$22.97 M(+23.3%) | -$72.22 M(+16.3%) |
| Mar 2012 | - | -$18.63 M(+13.5%) | -$62.11 M(-13.0%) |
| Dec 2011 | -$71.40 M(+190.9%) | -$16.42 M(+15.5%) | -$71.40 M(+16.4%) |
| Sept 2011 | - | -$14.21 M(+10.6%) | -$61.34 M(+10.3%) |
| June 2011 | - | -$12.85 M(-54.0%) | -$55.63 M(+16.1%) |
| Mar 2011 | - | -$27.93 M(+339.0%) | -$47.90 M(+95.2%) |
| Dec 2010 | -$24.55 M(+102.5%) | -$6.36 M(-25.2%) | -$24.55 M(+10.5%) |
| Sept 2010 | - | -$8.50 M(+66.1%) | -$22.21 M(+36.4%) |
| June 2010 | - | -$5.12 M(+12.0%) | -$16.28 M(+21.9%) |
| Mar 2010 | - | -$4.57 M(+13.4%) | -$13.36 M(+10.2%) |
| Dec 2009 | -$12.12 M(-52.7%) | -$4.03 M(+56.8%) | -$12.12 M(-4.2%) |
| Sept 2009 | - | -$2.57 M(+17.2%) | -$12.66 M(-19.4%) |
| June 2009 | - | -$2.19 M(-34.2%) | -$15.71 M(-22.0%) |
| Mar 2009 | - | -$3.33 M(-27.0%) | -$20.13 M(-21.4%) |
| Dec 2008 | -$25.62 M(-10.3%) | -$4.56 M(-18.8%) | -$25.62 M(-12.1%) |
| Sept 2008 | - | -$5.62 M(-15.1%) | -$29.15 M(-7.1%) |
| June 2008 | - | -$6.62 M(-25.0%) | -$31.39 M(-1.8%) |
| Mar 2008 | - | -$8.82 M(+8.9%) | -$31.97 M(+11.9%) |
| Dec 2007 | -$28.57 M(+49.5%) | -$8.10 M(+3.0%) | -$28.57 M(+7.0%) |
| Sept 2007 | - | -$7.86 M(+9.3%) | -$26.69 M(+17.3%) |
| June 2007 | - | -$7.20 M(+32.8%) | -$22.76 M(+7.1%) |
| Mar 2007 | - | -$5.42 M(-12.9%) | -$21.26 M(+11.2%) |
| Dec 2006 | -$19.11 M(+95.3%) | -$6.22 M(+58.3%) | -$19.11 M(+23.7%) |
| Sept 2006 | - | -$3.93 M(-30.9%) | -$15.45 M(+7.4%) |
| June 2006 | - | -$5.69 M(+73.8%) | -$14.38 M(+33.2%) |
| Mar 2006 | - | -$3.27 M(+28.2%) | -$10.80 M(+10.3%) |
| Dec 2005 | -$9.79 M(+71.5%) | -$2.55 M(-10.7%) | -$9.79 M(-0.8%) |
| Sept 2005 | - | -$2.86 M(+35.6%) | -$9.87 M(+18.0%) |
| June 2005 | - | -$2.11 M(-6.9%) | -$8.36 M(+33.4%) |
| Mar 2005 | - | -$2.26 M(-14.1%) | -$6.27 M(+56.3%) |
| Dec 2004 | -$5.71 M(+3454.5%) | -$2.64 M(+94.8%) | -$4.01 M(+165.4%) |
| Sept 2004 | - | -$1.35 M(+8255.6%) | -$1.51 M(+805.9%) |
| June 2004 | - | -$16.20 K(+145.5%) | -$166.90 K(+6.1%) |
| Mar 2004 | - | -$6600.00(-95.1%) | -$157.30 K(-2.1%) |
| Dec 2003 | -$160.60 K(+302.5%) | -$135.60 K(+1495.3%) | -$160.60 K(+348.6%) |
| Sept 2003 | - | -$8500.00(+28.8%) | -$35.80 K(+5.6%) |
| June 2003 | - | -$6600.00(-33.3%) | -$33.90 K(-16.7%) |
| Mar 2003 | - | -$9900.00(-8.3%) | -$40.70 K(+1.8%) |
| Dec 2002 | -$39.90 K(-45.0%) | -$10.80 K(+63.6%) | -$40.00 K(-42.5%) |
| Sept 2002 | - | -$6600.00(-50.7%) | -$69.60 K(-0.4%) |
| June 2002 | - | -$13.40 K(+45.7%) | -$69.90 K(+2.3%) |
| Mar 2002 | - | -$9200.00(-77.2%) | -$68.30 K(-5.8%) |
| Dec 2001 | -$72.50 K | -$40.40 K(+485.5%) | -$72.50 K(+125.9%) |
| Sept 2001 | - | -$6900.00(-41.5%) | -$32.10 K(+8.1%) |
| June 2001 | - | -$11.80 K(-11.9%) | -$29.70 K(-36.8%) |
| Mar 2001 | - | -$13.40 K(+197.8%) | -$47.00 K(+39.9%) |
| Sept 2000 | - | -$4500.00(-84.5%) | -$33.60 K(+15.5%) |
| June 2000 | - | -$29.10 K | -$29.10 K |
FAQ
- What is Alaunos Therapeutics annual operaing income?
- What is the all time high annual operating profit for Alaunos Therapeutics?
- What is Alaunos Therapeutics annual operating profit year-on-year change?
- What is Alaunos Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Alaunos Therapeutics?
- What is Alaunos Therapeutics quarterly operating profit year-on-year change?
- What is Alaunos Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Alaunos Therapeutics?
- What is Alaunos Therapeutics TTM operating profit year-on-year change?
What is Alaunos Therapeutics annual operaing income?
The current annual operating profit of TCRT is -$28.49 M
What is the all time high annual operating profit for Alaunos Therapeutics?
Alaunos Therapeutics all-time high annual operaing income is -$39.90 K
What is Alaunos Therapeutics annual operating profit year-on-year change?
Over the past year, TCRT annual operaing income has changed by +$6.75 M (+19.14%)
What is Alaunos Therapeutics quarterly operating income?
The current quarterly operating profit of TCRT is -$1.15 M
What is the all time high quarterly operating profit for Alaunos Therapeutics?
Alaunos Therapeutics all-time high quarterly operating income is -$4500.00
What is Alaunos Therapeutics quarterly operating profit year-on-year change?
Over the past year, TCRT quarterly operating income has changed by +$6.08 M (+84.10%)
What is Alaunos Therapeutics TTM operating income?
The current TTM operating profit of TCRT is -$7.42 M
What is the all time high TTM operating profit for Alaunos Therapeutics?
Alaunos Therapeutics all-time high TTM operating income is -$29.10 K
What is Alaunos Therapeutics TTM operating profit year-on-year change?
Over the past year, TCRT TTM operating income has changed by +$26.24 M (+77.96%)